Population pharmacokinetics of nalbuphine after surgery in children

British Journal of Anaesthesia

Volumn 106, Issue 4, 2011, Pages 558-565

  Bressolle, F ^a   Khier, S ^a   Rochette, A ^b   Kinowski, J M ^c   Dadure, C ^b   Capdevila, X ^b  

^a UNIV MONTPELLIER   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

children; population pharmacokinetics; surgery, laparoscopy

Indexed keywords

NALBUPHINE;

ACCURACY; AGE DISTRIBUTION; ALLOMETRY; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DROWSINESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MALE; MEDICAL INFORMATION; NAUSEA; POPULATION MODEL; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URINE RETENTION; VALIDATION PROCESS;

EID: 79952931251     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer001     Document Type: Article

References (24)

1. Errick JK, Heel RC. Nalbuphine: A preliminary review of its pharmacological properties and therapeutic efficacy. Drugs 1983; 26: 191-211 (Pubitemid 13033176)
2. Beaver WT, Feise GA. A comparison of the analgesic effect of intramuscular nalbuphine and morphine in patients with postoperative pain. J Pharmacol Exp Ther 1978; 204: 487-96 (Pubitemid 8290152)
3. Miller RR. Evaluation of nalbuphine hydrochloride. Am J Hosp Pharm 1980; 37: 942-9 (Pubitemid 11244273)
4. Jaillon P, Gardin ME, Lecocq B, et al. Pharmacokinetics of nalbuphine in infants, young healthy volunteers and elderly patients. Clin Pharmacol Ther 1989; 46: 226-33 (Pubitemid 19219960)
5. Nies AS, Shand DG, Wilkinson GR. Altered hepatic blood flow and drug disposition. Clin Pharmacokinet 1976; 1: 135-55
6. Aitkenhead AR, Lin ES, Achola KJ. The pharmacokinetics of oral and intravenous nalbuphine in healthy volunteers. Br J Clin Pharmacol 1988; 25: 264-8
7. Nicolle E, Devillier P, Delanoy B, Durand C, Bessard G. Therapeutic monitoring of nalbuphine: Transplacental transfer and estimated pharmacokinetics in the neonate. Eur J Clin Pharmacol 1996; 49: 485-9 (Pubitemid 26096387)
8. Jacqz-Aigrain E, Debillon T, Daoud P, et al. Population pharmacokinetics of nalbuphine in neonates. Paediatr Perinat Drug Ther 2003; 5: 190-8 (Pubitemid 38281491)
9. Bouwmeester NJ, Van Den Anker JN, Hop WC, Anand KJ, Tibboel D. Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants. Br J Anaesth 2003; 90: 642-52 (Pubitemid 36592339)
10. de Hoog M, Mouton JW, van den Anker JN. Thoughts on 'Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates'. Ther Drug Monit 2003; 25: 256-7
11. Singh J, Burr J, Stringham D, Arrieta A. Commonly used antibacterial and antifungal agents for hospitalized paediatric patients. Implications for therapy with an emphasis on clinical pharmacokinetics. Paediatr Drugs 2001; 3: 733-61 (Pubitemid 33032909)
12. Büttner W, Finke W. Analysis of behavioural and physiological parameters for the assessment of postoperative analgesic demand in newborns, infants and young children: A comprehensive report on seven consecutive studies. Paediatr Anaesth 2000; 10: 303-18 (Pubitemid 30331173)
13. Beal SL, Sheiner LB. NONMEM User's Guide. San Francisco: University of California at San Francisco, 1994
14. Research Development Population Pharmacokinetics. Visual-NM User's Manual, version 5.1. Montpellier: Research Development Population Pharmacokinetics, 1998
15. Anderson BJ, Meakin GH. Scaling for size: Some implications for paediatric anaesthesia dosing. Paediatr Anaesth 2002; 12: 205-19 (Pubitemid 34264439)
16. Tod M, Jullien V, Pons G. Facilitation of drug evaluation in children by population methods and modelling. Clin Pharmacokinet 2008; 47: 231-43 (Pubitemid 351367434)
17. Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303-32 (Pubitemid 351738156)
18. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986; 1: 54-77
19. Anderson BJ, Pons G, Autret-Leca E, Allegaert K, Boccard E. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: A population analysis. Paediatr Anaesth 2005; 15: 282-92 (Pubitemid 40462802)
20. Stringer RA, Strain-Damerell C, Nicklin P, Houston JB. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions. Drug Metab Dispos 2009; 37: 1025-34
21. Emoto C, Murayama N, Yamazaki H. Effects of enzyme sources on midazolam 1'-hydroxylation activity catalyzed by recombinant cytochrome P450 3A4 in combination with NADPH-cytochrome P450 reductase. Drug Metab Lett 2008; 2: 190-2
22. Available from http://www.medscape.com/viearticle/410825-4 (accessed 21 September 2010)
23. Rey E, Delaunay L, Pons G, et al. Pharmacokinetics of midazolam in children: Comparative study of intranasal and intravenous administration. Eur J Clin Pharmacol 1991; 41: 4355-7
24. Feierman DE. The effect of paracetamol (acetaminophen) on fentanyl metabolism in vitro. Acta Anaesthesiol Scand 2000; 44: 560-3 (Pubitemid 30233021)